Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $5.42 million. The enterprise value is $612,835.
Important Dates
The last earnings date was Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLRX has 5.86 million shares outstanding. The number of shares has increased by 267.48% in one year.
| Current Share Class | 5.86M |
| Shares Outstanding | 5.86M |
| Shares Change (YoY) | +267.48% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 0.12% |
| Float | 5.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.21 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.28
| Current Ratio | 3.28 |
| Quick Ratio | 2.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -139.55% and return on invested capital (ROIC) is -92.78%.
| Return on Equity (ROE) | -139.55% |
| Return on Assets (ROA) | -69.91% |
| Return on Invested Capital (ROIC) | -92.78% |
| Return on Capital Employed (ROCE) | -131.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.50M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.94% in the last 52 weeks. The beta is 0.33, so SLRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -95.94% |
| 50-Day Moving Average | 3.15 |
| 200-Day Moving Average | 9.44 |
| Relative Strength Index (RSI) | 25.06 |
| Average Volume (20 Days) | 5,108,618 |
Short Selling Information
The latest short interest is 467,881, so 7.98% of the outstanding shares have been sold short.
| Short Interest | 467,881 |
| Short Previous Month | 360,165 |
| Short % of Shares Out | 7.98% |
| Short % of Float | 8.48% |
| Short Ratio (days to cover) | 0.12 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.57M |
| Pretax Income | -5.00M |
| Net Income | -5.00M |
| EBITDA | -5.56M |
| EBIT | -5.57M |
| Earnings Per Share (EPS) | -$33.53 |
Full Income StatementBalance Sheet
The company has $4.81 million in cash and n/a in debt, giving a net cash position of $4.81 million or $0.82 per share.
| Cash & Cash Equivalents | 4.81M |
| Total Debt | n/a |
| Net Cash | 4.81M |
| Net Cash Per Share | $0.82 |
| Equity (Book Value) | 4.25M |
| Book Value Per Share | 4.50 |
| Working Capital | 4.22M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.43M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.43M |
| FCF Per Share | -$0.76 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
